Although, the popularity of prostate-specific antigen (PSA) screening technology has increased the rate of diagnosis and the treatment of prostate cancer, where early prostate cancer can be completely cured, yet about 10% to 20% of the newly diagnosed prostate cancer patients are at their advanced stages [2]. The gene discussed is KLK3; the disease is prostate carcinoma.